I Wayan Sumardika
Overview
Explore the profile of I Wayan Sumardika including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Saito K, Iioka H, Maruyama S, Sumardika I, Sakaguchi M, Kondo E
Neoplasia
. 2019 Nov;
21(12):1121-1132.
PMID: 31759250
Pancreatic invasive ductal adenocarcinoma (PDAC) is a representative intractable malignancy under the current cancer therapies, and is considered a scirrhous carcinoma because it develops dense stroma. Both PODXL1, a member...
12.
Chen Y, Sumardika I, Tomonobu N, Kinoshita R, Inoue Y, Iioka H, et al.
Neoplasia
. 2019 May;
21(7):627-640.
PMID: 31100639
Metastatic breast cancer is the leading cause of cancer-associated death in women. The progression of this fatal disease is associated with inflammatory responses that promote cancer cell growth and dissemination,...
13.
Mitsui Y, Tomonobu N, Watanabe M, Kinoshita R, Sumardika I, Youyi C, et al.
Oncol Res
. 2019 May;
27(8):945-956.
PMID: 31046874
S100A11, a member of the S100 family of proteins, is actively secreted from pancreatic ductal adenocarcinoma (PDAC) cells. However, the role of the extracellular S100A11 in PDAC progression remains unclear....
14.
Chen Y, Sumardika I, Tomonobu N, Ruma I, Kinoshita R, Kondo E, et al.
Cancer Lett
. 2019 Mar;
452:178-190.
PMID: 30904617
Since metastasis accounts for the majority of cancer-associated deaths, studies on the mechanisms of metastasis are needed to establish innovative strategies for cancer treatment. We previously reported that melanoma cell...
15.
Tomonobu N, Kinoshita R, Sumardika I, Chen Y, Inoue Y, Yamauchi A, et al.
Biochem Biophys Rep
. 2019 Mar;
18:100619.
PMID: 30899801
Mouse melanoma B16-BL6 cells are useful cells for cancer metastatic studies. To understand the metastatic principle at molecular levels, it is necessary to carry out experiments in which cancer cells...
16.
Takamatsu H, Yamamoto K, Tomonobu N, Murata H, Inoue Y, Yamauchi A, et al.
Oncol Res
. 2019 Mar;
27(6):713-727.
PMID: 30850029
The fertile stroma in pancreatic ductal adenocarcinomas (PDACs) has been suspected to greatly contribute to PDAC progression. Since the main cell constituents of the stroma are fibroblasts, there is crosstalking(s)...
17.
Sumardika I, Chen Y, Tomonobu N, Kinoshita R, Ruma I, Sato H, et al.
Mol Carcinog
. 2019 Feb;
58(6):980-995.
PMID: 30720226
Compiling evidence indicates an unusual role of extracellular S100A8/A9 in cancer metastasis. S100A8/A9 secreted from either cancer cells or normal cells including epithelial and inflammatory cells stimulates cancer cells through...
18.
Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika I, et al.
Int J Cancer
. 2018 Nov;
145(2):569-575.
PMID: 30414170
The metastatic dissemination of cancer cells to remote areas of the body is the most problematic aspect in cancer patients. Among cancers, melanomas are notoriously difficult to treat due to...
19.
Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika I, et al.
Int J Cancer
. 2018 Oct;
144(12):3138-3145.
PMID: 30365872
Within the "seed and soil" theory of organ tropic cancer metastasis is a growing compilation of evidence that S100A8/A9 functions as a soil signal that attracts cancer cells to certain...
20.
Saito K, Sakaguchi M, Maruyama S, Iioka H, Putranto E, Sumardika I, et al.
J Cancer
. 2018 Aug;
9(16):2916-2929.
PMID: 30123360
Pancreatic ductal adenocarcinoma (PDAC) is currently one of the most intractable malignancies with a typical scirrhous pattern in histology. Due to its abundant tumor stroma and scant vascularization, chemotherapeutic agents...